Cargando…

Rational and design of SATRACD study: detecting subclinical anthracycline therapy related cardiac dysfunction in low income country

BACKGROUND: Anthracycline therapy-related cardiac dysfunction (ATRCD) is the most notorious adverse side-effect of chemotherapy. It has become a significant cardiovascular health concern for long-term cancer survivors. With the emerging concept of subclinical ATRCD and newer diagnostictools (Speckle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wanzhu, Azibani, Feriel, Okello, Emmy, Kayima, James, Walusansa, Victoria, Orem, Jackson, Sliwa, Karen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Makerere Medical School 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568225/ https://www.ncbi.nlm.nih.gov/pubmed/34795719 http://dx.doi.org/10.4314/ahs.v21i2.21

Ejemplares similares

The role of conventional echocardiographic parameters on detecting subclinical anthracycline therapy related cardiac dysfunction—The SATRACD study
por: Zhang, Wanzhu, et al.
Publicado: (2022)

Clinical characterization, cardiovascular risk factor profile and cardiac strain analysis in a Uganda cancer population: The SATRACD study
por: Zhang, Wanzhu, et al.
Publicado: (2021)

Anthracycline induced cardiotoxicity in adult cancer patients: a prospective cohort study from a specialized oncology treatment centre in Uganda
por: Kibudde, Solomon, et al.
Publicado: (2019)

Peripartum Cardiomyopathy: an Update
por: Azibani, Feriel, et al.
Publicado: (2018)

Presenting features of newly diagnosed rheumatic heart disease patients in Mulago Hospital: a pilot study
por: Mondo, Charles, et al.
Publicado: (2013)

Subclinical Ventricular Dysfunction Detected by Speckle Tracking Two Years after Use of Anthracycline
por: de Almeida, André Luiz Cerqueira, et al.
Publicado: (2015)

Subclinical Ventricular Dysfunction Detected by Speckle-Tracking Two Years after Use of Anthracycline
por: Freitas Jr., Aguinaldo Figueiredo, et al.
Publicado: (2015)

Gene Therapy for LMNA-related Congenital Muscular Dystrophy (L-CMD) by Trans-Splicing
por: Azibani, Feriel, et al.
Publicado: (2015)

Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
por: Hu, Hui-Min, et al.
Publicado: (2018)

Clinical profile and initial treatment of non-small cell lung cancer: a retrospective cohort study at the Uganda Cancer Institute
por: Kibudde, Solomon, et al.
Publicado: (2021)

Use of integrated imaging and serum biomarker profiles to identify subclinical dysfunction in pediatric cancer patients treated with anthracyclines
por: Toro-Salazar, Olga H., et al.
Publicado: (2018)

Cardiac Surveillance for Early Detection of Late Subclinical Cardiac Dysfunction in Childhood Cancer Survivors After Anthracycline Therapy
por: Sofia, Rosaria, et al.
Publicado: (2021)

Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children
por: Gantt, Soren, et al.
Publicado: (2010)

Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
por: Zhou, Xi, et al.
Publicado: (2023)

Anthracycline dose and liver dysfunction
por: Cannizzaro, R, et al.
Publicado: (1999)

Monitoring Sustainable Development Goal 3: how ready are the health information systems in low-income and middle-income countries?
por: Nabyonga-Orem, Juliet
Publicado: (2017)

Cardiovascular diseases in Africa in the twenty-first century: Gaps and priorities going forward
por: Minja, Neema W., et al.
Publicado: (2022)

Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines
por: Barbosa, Maurício Fregonesi, et al.
Publicado: (2021)

Evaluation of anthracycline-induced subclinical LV dysfunction by using myocardial composite index and two-dimension speckle tracking echocardiography technique
por: Zhu, Jiabao, et al.
Publicado: (2022)

Behavioural interventions to address rational use of antibiotics in outpatient settings of low‐income and lower‐middle‐income countries
por: Nair, Mohit M., et al.
Publicado: (2021)

Side effects and acceptability measures for thermal ablation as a treatment for cervical precancer in low-income and middle-income countries: a systematic review and meta-synthesis
por: Piret, Evelyne Marie, et al.
Publicado: (2022)

Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP
por: Dong, Qian, et al.
Publicado: (2022)

Monitoring Sustainable Development Goals 3: Assessing the Readiness of Low- and Middle-Income Countries
por: Nabukalu, Joy Belinda, et al.
Publicado: (2019)

Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country
por: Minaei, Hossein, et al.
Publicado: (2019)

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
por: Murabito, Alessandra, et al.
Publicado: (2020)

Anthracycline-Induced Vascular Dysfunction: Is MitoQ the Answer?
por: Sawyer, Douglas B.
Publicado: (2020)

Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital
por: Musoke, Charles, et al.
Publicado: (2013)

Analysis of blood culture in a rat model of cecal ligation and puncture induced sepsis
por: Vaittinada Ayar, Prabakar, et al.
Publicado: (2020)

Alteration of the Renin–Angiotensin–Aldosterone System in Shock: Role of the Dipeptidyl Peptidase 3
por: Picod, Adrien, et al.
Publicado: (2021)

Supportive supervision to improve service delivery in low-income countries: is there a conceptual problem or a strategy problem?
por: Avortri, Gertrude Sika, et al.
Publicado: (2019)

Health systems performance assessment in low-income countries: learning from international experiences
por: Tashobya, Christine Kirunga, et al.
Publicado: (2014)

Policy dialogue to improve health outcomes in low income countries: what are the issues and way forward?
por: Nabyonga-Orem, Juliet, et al.
Publicado: (2016)

Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer
por: Kotwinski, Paul, et al.
Publicado: (2016)

Diffuse myocardial fibrosis by T(1)-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling
por: Tham, Edythe B, et al.
Publicado: (2013)

N‐terminal pro BNP and galectin‐3 are prognostic biomarkers of acute heart failure in sub‐Saharan Africa: lessons from the BAHEF trial
por: Sani, Mahmoud U., et al.
Publicado: (2020)

Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study
por: Narayan, Hari K, et al.
Publicado: (2017)

Women’s understanding and experiences of menopause in low-income and middle-income countries in the Asia Pacific region: a scoping review protocol
por: Cheer, Karen, et al.
Publicado: (2022)

Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)

Subclinical reduction in left ventricular function using triplane and 2D speckle tracking echocardiography after anthracycline exposure in children
por: Çilsal, Erman, et al.
Publicado: (2018)

Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis
por: Kang, Yu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gmjiejiuhhivo28vcrpe653mtd